Alyar, S. Et Al. 2023. Biochemical properties of Schiff Bases derived from FDA-approved Sulfa drugs: Synthesis, ADME/ Molecular Docking studies, and anticancer activity. JOURNAL OF MOLECULAR STRUCTURE , vol.1290 , 136167-136173.

Alyar, S., Alyar, H., Özdemir Özmen, Ü., Aktaş, O., & Erdem, K., (2023). Biochemical properties of Schiff Bases derived from FDA-approved Sulfa drugs: Synthesis, ADME/ Molecular Docking studies, and anticancer activity. JOURNAL OF MOLECULAR STRUCTURE , vol.1290, 136167-136173.

Alyar, Saliha Et Al. "Biochemical properties of Schiff Bases derived from FDA-approved Sulfa drugs: Synthesis, ADME/ Molecular Docking studies, and anticancer activity," JOURNAL OF MOLECULAR STRUCTURE , vol.1290, 136167-136173, 2023

Alyar, Saliha Et Al. "Biochemical properties of Schiff Bases derived from FDA-approved Sulfa drugs: Synthesis, ADME/ Molecular Docking studies, and anticancer activity." JOURNAL OF MOLECULAR STRUCTURE , vol.1290, pp.136167-136173, 2023

Alyar, S. Et Al. (2023) . "Biochemical properties of Schiff Bases derived from FDA-approved Sulfa drugs: Synthesis, ADME/ Molecular Docking studies, and anticancer activity." JOURNAL OF MOLECULAR STRUCTURE , vol.1290, pp.136167-136173.

@article{article, author={Saliha Alyar Et Al. }, title={Biochemical properties of Schiff Bases derived from FDA-approved Sulfa drugs: Synthesis, ADME/ Molecular Docking studies, and anticancer activity}, journal={JOURNAL OF MOLECULAR STRUCTURE}, year=2023, pages={136167-136173} }